Cansativa GmbH, a German cannabis distribution and wholesaler, has become the first European company to import Latin American medical cannabis samples for initial testing. The samples will be provided by Clever Leaves, a vertically integrated licensed producer of medical cannabis in Colombia, and Fotmer Life Sciences, a licensed medical cannabis producer in Uruguay.
“The importation of medical cannabis paves the way and brings us one step closer to commercializing medical cannabis in Germany. It also highlights our extensive reach and ability to import medical cannabis products from countries other than the Netherlands and Canada,” said Benedikt Sons, co-founder and joint managing director of Cansativa.
"Several different flower and extract products will be imported from South America which will then be tested by independent German laboratories for a number of properties, including but not limited to: microbiology, dry loss, assay, pesticides, heavy metal, aflatoxin and ochratoxin. Following the approval of German and European standards for medical products, Clever Leaves and Fotmer will work to demonstrate their ability to cultivate high quality pharmaceutical grade cannabis for future European commercialization," the company explains.
“Clever Leaves is producing pharmaceutical grade cannabis and extracts that clearly demonstrate that the Colombian market can meet international standards and produce high quality medical cannabis,” said Andrés Fajardo, CEO of Clever Leaves.
For more information: